Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market
Advertisement

Sarepta Therapeutics (SRPT) Technical Analysis

Compare
4,025 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is -0.97, suggesting Sarepta Therapeutics is a Buy.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 19.86, while Sarepta Therapeutics’s (SRPT) share price is $18.81, making it a Sell.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 20.55, while Sarepta Therapeutics’s (SRPT) share price is $18.81, making it a Sell.

Sarepta Therapeutics (SRPT) Pivot Points

Nov 16, 2025, 09:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.58
17.04
17.43
17.89
18.28
18.74
19.13
Fibonacci
17.04
17.36
17.57
17.89
18.21
18.41
18.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

Nov 16, 2025, 09:47 AM
Period
Simple
Exponential
MA5
17.98Buy
18.30Buy
MA10
18.45Buy
18.88Sell
MA20
20.82Sell
19.86Sell
MA50
20.25Sell
20.55Sell
MA100
19.00Sell
25.69Sell
MA200
42.66Sell
49.20Sell
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 18.88, while Sarepta Therapeutics’s (SRPT) share price is $18.81, making it a Sell.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 25.69, while Sarepta Therapeutics’s (SRPT) share price is $18.81, making it a Sell.
Sarepta Therapeutics’s (SRPT) stock price is $18.81 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 20.25, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $18.81 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 19.00, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $18.81 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 42.66, creating a Sell signal.

Sarepta Therapeutics (SRPT) Technical Indicators

Nov 16, 2025, 09:47 AM
Name
Value
Implied Action
RSI (14)
44.67
Neutral
STOCH (9,6)
44.45
Neutral
STOCHRSI (14)
33.05
Neutral
MACD (12,26)
-0.97
Buy
ADX (14)
28.66
Neutral
Williams %R
-60.61
Buy
CCI (14)
-47.76
Neutral
ATR (14)
1.72
-
Ultimate Oscillator
45.70
Neutral
ROC
-19.96
Sell
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 44.67, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 28.66, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is -47.76, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is -19.96, creating a Sell signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Sell.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 44.67, which suggests SRPT is a Neutral.
      What is SRPT’s MACD?
      SRPT’s MACD is -0.97, which suggests SRPT is a Buy.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 17.98, which suggests SRPT is a Buy.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 20.82, which suggests SRPT is a Sell.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 20.25, which suggests SRPT is a Sell.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 42.66, which suggests SRPT is a Sell.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -60.61, which suggests SRPT is a Buy.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is -47.76, which suggests SRPT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis